Dror Harats is the CEO of VBL Therapeutics, a clinical-stage biopharmaceutical company focused on developing therapies for cancer and inflammatory diseases.
Dr. Dror Harats is the CEO of VBL Therapeutics, a clinical-stage biopharmaceutical company focused on developing therapies for cancer and inflammatory diseases. As an MD, he has been involved in leading the company's Phase III clinical trials for various solid tumors. He is based in Israel and has been associated with VBL Therapeutics since at least 2017.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide